Niamh Madigan | 05/07/2013
Douglas Ball, Research Fellow at Pfizer, Inc. reflects on the major issues raised at the Disposable Solutions for Biomanufacturing conference in Belgium such as best manufacturing practice and regulatory guidance and how they apply to Biomanufacturing in the United States.
Have Your Say
Rate this feature and give us your feedback in the comments section below
To continue reading this story Click Here
RECOMMENDED
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Sustainability and Inclusivity in Pharma Manufacturing: Insights from AstraZeneca’s People Hub
2024-12-11
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More